| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
35,985 |
22,389 |
$1.66M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
11,863 |
9,275 |
$790K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,793 |
1,778 |
$137K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,297 |
1,285 |
$105K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
8,156 |
7,859 |
$99K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
7,651 |
6,681 |
$67K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
4,457 |
4,245 |
$57K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
5,561 |
3,971 |
$48K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,436 |
1,351 |
$44K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
514 |
507 |
$34K |
| 92551 |
|
4,791 |
4,655 |
$34K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
495 |
495 |
$33K |
| 92587 |
|
1,268 |
1,246 |
$30K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
1,786 |
1,518 |
$17K |
| 99050 |
|
1,755 |
1,514 |
$15K |
| G0008 |
Administration of influenza virus vaccine |
766 |
765 |
$14K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
1,466 |
1,445 |
$14K |
| 90473 |
|
2,079 |
1,617 |
$14K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,115 |
997 |
$11K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
114 |
114 |
$11K |
| 99173 |
|
7,051 |
6,814 |
$9K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
619 |
548 |
$7K |
| 99188 |
|
179 |
178 |
$4K |
| 90656 |
|
294 |
294 |
$3K |
| 90734 |
|
37 |
37 |
$2K |
| 90651 |
|
25 |
25 |
$2K |
| 90686 |
|
157 |
157 |
$2K |
| 90474 |
|
560 |
464 |
$817.97 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
31 |
28 |
$420.00 |
| 90715 |
|
21 |
21 |
$291.13 |
| 99000 |
|
2,264 |
1,746 |
$6.88 |
| 3008F |
|
34 |
34 |
$3.00 |
| 99001 |
|
184 |
170 |
$0.00 |
| A7003 |
Administration set, with small volume nonfiltered pneumatic nebulizer, disposable |
16 |
15 |
$0.00 |